164 related articles for article (PubMed ID: 16097921)
1. Phaeochromocytoma: current concepts.
Alderazi Y; Yeh MW; Robinson BG; Benn DE; Sywak MS; Learoyd DL; Delbridge LW; Sidhu SB
Med J Aust; 2005 Aug; 183(4):201-4. PubMed ID: 16097921
[TBL] [Abstract][Full Text] [Related]
2. Phaeochromocytoma in children.
Armstrong R; Sridhar M; Greenhalgh KL; Howell L; Jones C; Landes C; McPartland JL; Moores C; Losty PD; Didi M
Arch Dis Child; 2008 Oct; 93(10):899-904. PubMed ID: 18499773
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].
van der Kleij-Corssmit EP; Havekes B; Vriends AH; Jansen JC; Romijn JA
Ned Tijdschr Geneeskd; 2008 Mar; 152(9):489-93. PubMed ID: 18389879
[TBL] [Abstract][Full Text] [Related]
4. Plasma neuropeptide Y and catecholamine concentrations and urinary metanephrine excretion in patients with adrenal or ectopic phaeochromocytoma.
Plouin PF; Chatellier G; Grouzmann E; Azizi M; Denolle T; Comoy E; Corvol P
J Hypertens Suppl; 1991 Dec; 9(6):S272-3. PubMed ID: 1818966
[No Abstract] [Full Text] [Related]
5. Phaeochromocytoma: state-of-the-art.
Donckier JE; Michel L
Acta Chir Belg; 2010; 110(2):140-8. PubMed ID: 20514823
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary phaeochromocytoma in twins].
Tóth G; Patócs A; Tóth M
Orv Hetil; 2016 Aug; 157(33):1326-30. PubMed ID: 27523316
[TBL] [Abstract][Full Text] [Related]
7. Phaeochromocytoma and Paraganglioma.
Gunawardane PTK; Grossman A
Adv Exp Med Biol; 2017; 956():239-259. PubMed ID: 27888488
[TBL] [Abstract][Full Text] [Related]
8. SDHD-related chromaffin tumours: disease localisation to genetic dysfunction.
Srirangalingam U; Khoo B; Matson M; Carpenter R; Reznek R; Maher ER; Chew SL; Drake WM
Horm Res Paediatr; 2010; 73(2):135-9. PubMed ID: 20190551
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
10. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
Lalloo F
Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
[TBL] [Abstract][Full Text] [Related]
12. Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.
Jasperson KW; Kohlmann W; Gammon A; Slack H; Buchmann L; Hunt J; Kirchhoff AC; Baskin H; Shaaban A; Schiffman JD
Fam Cancer; 2014 Jun; 13(2):257-65. PubMed ID: 23934599
[TBL] [Abstract][Full Text] [Related]
13. An elusive phaeochromocytoma.
Yates CJ; McAuley SA; Grodski S; Hamblin PS; Ebeling PR
Med J Aust; 2011 Jan; 194(1):44-5. PubMed ID: 21449869
[No Abstract] [Full Text] [Related]
14. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
15. Consideration of the degree of increase in urine metadrenalines provides superior specificity in the diagnosis of phaeochromocytoma than additional urine catecholamine measurement.
Scargill JJ; Reed P; Kane J
Ann Clin Biochem; 2013 Jan; 50(Pt 1):73-5. PubMed ID: 23417444
[TBL] [Abstract][Full Text] [Related]
16. Subclinical phaeochromocytoma.
Mannelli M; Lenders JW; Pacak K; Parenti G; Eisenhofer G
Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):507-15. PubMed ID: 22863392
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
Pacak K; Eisenhofer G; Ahlman H; Bornstein SR; Gimenez-Roqueplo AP; Grossman AB; Kimura N; Mannelli M; McNicol AM; Tischler AS;
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):92-102. PubMed ID: 17237836
[TBL] [Abstract][Full Text] [Related]
18. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines.
Lenders JW; Pacak K; Eisenhofer G
Ann N Y Acad Sci; 2002 Sep; 970():29-40. PubMed ID: 12381539
[TBL] [Abstract][Full Text] [Related]
19. [Management of incidentalomas].
Duclos JM
Prog Urol; 1992; 2(4):653-9. PubMed ID: 1302107
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of endocrine disease: Biochemical diagnosis of phaeochromocytoma and paraganglioma.
van Berkel A; Lenders JW; Timmers HJ
Eur J Endocrinol; 2014 Mar; 170(3):R109-19. PubMed ID: 24347425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
